Qisda Begins to Tap Southeast Asia Medical Device Market


Reading time ( words)

EMS provider Qisda has begun to tap the Southeast Asia market for medical devices, as K2 International Medical, in which Qisda holds a 37.56% stake, has announced the establishment of a subsidiary in Thailand to market hemodialyzers, hemodialysis services, and aesthetic medical products and services there, according to a Digitimes report.

Founded in 2006, K2 International distributes hemodialyzers, blood transfusion/purification and aesthetic medical products, and provides related services, and has served more than 100 hospitals and hemodialysis centers in Taiwan and China. Qisda, viewing that K2 International can complement its subsidiary BenQ Dialysis Technology's business, invested in it in September 2018.

Share

Print


Suggested Items

Award-winning Koh Young Process Optimizer

02/18/2019 | Dan Beaulieu
Joel Scutchfield, sales director with Koh Young America, discusses the company's outlook and new product offerings for 2019, including their Koh Young Process Optimizer (KPO), which won an award at IPC APEX EXPO 2019 for the process control software category.

Top 10 Most-Read SMT007 Articles of 2018

12/28/2018 | Stephen Las Marias, I-Connect007
Every year, we like to take a look back at the most popular SMT007 news, articles, interviews, and columns. These are the top 10 most-read SMT007 articles from the past year. Check them out.

Seeing Clearly: XR Headsets and Flex’s Reference Design at AWE

06/26/2018 | Dan Feinberg, Technology Editor, I-Connect007
At this year’s CES, they announced the launch of an extended reality (XR) reference design for the next generation of XR headsets. As the “sketch-to-scale” solutions provider, as they describe themselves, that designs and builds “intelligent products for a connected world,” they have now introduced an augmented reality (AR or, as we now call it, XR) reference design to reduce time to market for companies wishing to make and market XR devices.



Copyright © 2019 I-Connect007. All rights reserved.